濮阳东方医院男科治阳痿评价好很不错(濮阳东方看妇科病价格不贵) (今日更新中)

SAN FRANCISCO, Dec. 9 (Xinhua) -- Hewlett-Packard (HP) on Friday announced that it is keeping the webOS software alive by contributing it to the open source community.The company said it will make the underlying code of webOS available under an open source license and will engage the open source community to help define the charter of the open source project."WebOS is the only platform designed from the ground up to be mobile, cloud-connected and scalable," Meg Whitman, HP's chief executive officer, said in a statement."By contributing this innovation, HP unleashes the creativity of the open source community to advance a new generation of applications and devices," she added.HP said it will remain active in the development and support of webOS, while the source code will be available for use and improvement by anyone choosing to download it, which means other hardware manufacturers can also use the software.With the help of the open source community, HP can save development and other costs and the new announcement is expected to result in more layoffs from its webOS team, some analysts noted.The webOS is a mobile operating system initially developed by Palm which was acquired by HP last April for 1.2 billion U.S. dollars.In February this year, HP released TouchPad, its first tablet computer which runs the webOS operating system. The device didn't sell well, and HP in August decided to completely shut down webOS hardware business, including TouchPad and webOS phones.HP then said that it will continue to explore options to optimize the value of webOS software going forward.By keeping the software open source, users of webOS devices will continue to receive software improvements and updates in the future, HP noted."As webOS gains traction as an open source alternative in the marketplace, you could see webOS on several different types of devices by any number of vendors. We will explore the viability of putting webOS on devices, just as we do for other leading operating systems," the company said in a corporate blog post.

WASHINGTON, Oct. 3 (Xinhua) -- Overweight or obesity may put children at three times greater risk for high blood pressure than those of normal weight, according to researchers from the Regenstrief Institute and Indiana University (IU) School of Medicine.Their study will appear in the November issue of Hypertension: Journal of the American Heart Association with advance online publication on Monday.More than 1,100 healthy Indiana school children were followed for nearly five years. The researchers found that when body mass index (BMI) reached or exceeded the 85th percentile for the age and gender of the child -- designated as being overweight -- the risk of high blood pressure nearly tripled. Obesity was defined as a BMI percentile higher than 95th. BMI is a measurement of body fat calculated from weight and height.Among study participants, 14 percent of overweight or obese children were pre-hypertensive or hypertensive, compared with 5 percent of normal weight children. These findings were consistent across age, gender and race.The average age at time of study enrollment was 10.2 years. Each child was assessed approximately eight times during the course of the study. All were healthy children and none were taking medication affecting blood pressure."Higher blood pressure in childhood sets the stage for high blood pressure in adulthood," said Regenstrief Institute Investigator Wanzhu Tu, professor of biostatistics at IU School of Medicine, who led the study. "Targeted interventions are needed for these children. Even small decreases in BMI could yield major health benefits."The researcher also found that leptin, a protein hormone which is involved in body weight regulation and metabolism, was positively associated with increased blood pressure in overweight and obese children.

BEIJING, Oct. 7 (Xinhua) -- Chinese scientists are developing new methods like spraying or dropping hepatitis vaccines into people's noses to replace traditional injections, according to a leading expert on immunology.Such researches were sponsored by a key national science project, according to Wen Yumei, an academician of the Chinese Academy of Engineering, also the chairwoman of the 14th International Symposium on Viral Hepatitis and Liver Disease, which is scheduled to be held in Shanghai next July.At a press conference held here Friday for the symposium, experts believed that broad-coverage inoculations is an effective way in facilitating the country's goal in controlling Hepatitis B.China's Ministry of Health has also credited its national immunization program for having protected about 80 million people from being infected with the Hepatitis B virus (HBV) in the 19 years after 1992.Recent report showed that about 93 million Chinese are HBV carriers, accounting for more than a quarter of the world's total.

BEIJING, Sept. 30 (Xinhuanet) -- China's space dream took a step closer to reality as the Tiangong-1 module blasted off into the night sky on Thursday from the Gobi Desert.The Long March II-F T1 rocket, under the unmanned module, Tiangong-1, lifted off from the Jiuquan Satellite Launch Center at 9:16 pm as planned.Ten minutes later Tiangong-1 separated from the rocket on its way to orbit, 350 kilometers above Earth. The module deployed its two solar panels, which provide power, at 9:28 pm.At 9:39 pm, Chang Wanquan, chief commander of the manned space program, declared the launch a success as cheers and applause echoed around the command and control center in Beijing.President Hu Jintao and other members of the Standing Committee of the Political Bureau of the Communist Party of China Central Committee went to the center to witness the launch.Premier Wen Jiabao watched at the Jiuquan Satellite Launch Center as the Long March rocket, carrying the space lab, blazed into the night sky.The launch paves the way for China's first rendezvous and docking mission. An unmanned Shenzhou VIII spaceship will be launched in November to dock with Tiangong-1.Two more missions are scheduled for next year and astronauts will board Tiangong-1, which can also function as a space lab.If the mission succeeds, China will become the third country to master spacecraft rendezvous and docking technology following the then Soviet Union and the United States, experts said.Wu Ping, the space program's spokeswoman, said that the ability to rendezvous and dock is vital for building a space station, which China has scheduled for around 2020."A space station cannot be launched in one shot. The modules must be launched separately and then assembled in space," she said.China has invested 35 billion yuan (.47 billion) in total on its manned space program since 1992, when it was approved, she told China Daily.The first phase, from 1992 to 2005, accounted for 20 billion yuan. During this period, China launched six Shenzhou spaceships to set up a system transporting astronauts between Earth and space.In the second phase, from 2005, 15 billion yuan has been spent on projects, including Shenzhou VII and the first rendezvous and docking mission, she explained.Zhou Jianping, chief designer of China's manned space program, said that the space lab and future space station provide a rare platform for conducting experiments that could lead to breakthroughs in the study of materials and biological pharmacy."Experiments made in the microgravity of space can lead to unexpected results," he said.For example, gas and liquid are unable to mix on Earth, but in space they mix naturally, he said."The primary purpose of China's manned space station is to peacefully explore space, and through it, serve mankind," he said.Some have questioned the participation of the military in the program. However, the military has experience in coordinating large-scale requirements that are vital for the program and their involvement reflects international norms, Ministry of National Defense spokesman Geng Yansheng said on Wednesday.He reiterated that China is firmly opposed to the weaponization of space and the program is peaceful.China is now in the second phase of its manned space program. The goal of the program, which has three steps, is to build a 60-ton space station around 2020.The second phase focuses on mastering four key technologies for assembling a space station.The first of these, extravehicular activity, was completed successfully in 2008 after Shenzhou VII was launched.Rendezvous and docking is what is being experimented with. The third technology involves cargo spaceships ferrying supplies to a space lab. The fourth tackles problems concerning the prolonged sustaining of life on a space lab, especially recycling air and water.Besides the manned space program, China launched two lunar orbiters in 2007 and 2010. It plans an unmanned lunar landing around 2013, and returning moon samples in 2017.

BEIJING, Sept. 30 (Xinhuanet) -- The number of children being prescribed stimulants to treat attention deficit hyperactivity disorder (ADHD) has been steadily rising in the U.S. since 1996, researchers found.The finding was contained in a report released Wednesday in the U.S. medical journal Psychiatry.About 7.8 percent of children aged 4 to 17 in 2003 were diagnosed with ADHD, compared to 9.5 percent in 2007, according to the data gathered from the Health Resources and Services Administration's National Survey of Children's Health.And compared to 0.6 percent in 1987, 2.9 percent of children under 19 in 2002 have been prescribed stimulants, the report said.The finding raises the researchers' concern as stimulants have side effects such as decreased appetite, leeplessness and even heart-related damage, the report warned."Stimulant medications work well to control ADHD symptoms, but they are only one method of treatment for the condition. Experts estimate that about 60 percent of children with ADHD are treated with medication." says researcher Benedetto Vitiello, MD, of the U.S. National Institute of Mental Health."There is ongoing concern that these drugs may not be used properly, especially when they are prescribed to college students or children in their late adolescence who are more in charge of their care and may not be using the medications as prescribed." he added.

来源：资阳报